Close
Login to MyACC
ACC Members


Not a Member?

The Association of Corporate Counsel (ACC) is the world's largest organization serving the professional and business interests of attorneys who practice in the legal departments of corporations, associations, nonprofits and other private-sector organizations around the globe.

Join ACC

ACC Member Portal and Web Services are back online
ACC's member portal and web services are available following a scheduled upgrade. However, our team is monitoring and resolving issues promptly. Please be sure to reset your password here.
Thank you for your patience. Please contact our team with any questions.

Search Filters
Foley & Lardner LLP

This article provides recommendations on how to minimize regulatory risks associated with patient assistance programs in the United States.

Resource Details
Region: United States
Katlin McKelvie, Partner, and Carlo Felizardo, Associate (Gibson Dunn)

Navigating the complexities of a product recall can be challenging, but having a well-structured plan in place minimizes risks and ensures compliance.

In this checklist, we outline the six key steps every company should follow when faced with a potential recall—ranging from the initial determination of whether a recall is necessary to conducting a thorough after-action review. This guide can serve as a resource for any business looking to protect consumers and its brand during a recall event.

Resource Details
Region: United States
Christi A. Lawson, Whitney Nicholas, and Natasha Dempsey (Foley & Lardner LLP)
2 pages

This article discuses the Federal Trade Commission (FTC) finalized amendments to the Negative Option Rule, now retitled the “Rule Concerning Recurring Subscriptions and Other Negative Option Program.“

The rule represents a significant overhaul of the regulatory framework governing how companies handle subscription services and automatic renewals.

Judith A. Waltz and Daniel S. Costandy (Foley & Lardner LLP)

4 pages

This article discusses the Center for Medicare & Medicaid Services (CMS) final regulation interpreting the 60-day Refund Rule for Medicare Parts A/B (Traditional Medicare) and C/D (Medicare Advantage (MA) and the Prescription Drug Plans).

Resource Details
Interest Area: Health Law
Region: United States

Entities in the healthcare space that engage independent sales representatives to promote their or others' products should be mindful of the regulatory considerations and risks associated with how those representatives are compensated. Kyle Faget and Larry Vernaglia from the HLN's sponsor firm, Foley & Lardner LLP, will discuss how such representatives are compensated, what risks are involved, and what steps you should consider to help ensure that those arrangements will withstand legal scrutiny.

Generously sponsored by Foley & Lardner LLP

image

Melinda Levitt and Alex Maulden (Foley & Lardner LLP)

This resource covers how to create and enforce effective document retention policies, especially for organizations in the health-care industry.

Jennifer Hennessy, Foley & Lardner LLP

In February 2024, the U.S. Department of Health and Human Services (HHS) issued the much anticipated final rule to update the Confidentiality of Substance Abuse Disorder Patient Records regulations at 42 CFR Part 2 (Part 2).

This article discusses the amendments to Part 2 and its most impactful revisions, including the amendments to loosen patient consent requirements, regulate SUD counseling notes, and create new patient rights and breach notification requirements.

Resource Details
Region: United States

See the inside of an acquisition deal room in this case study-based session. Follow a healthcare company as they acquire a smaller specialty pharma company with an extensive IP portfolio from letter of intent to non-disclosure and due diligence. Solve issues as they arise and explore the negotiations progress through the perspective of both the acquiror and the target company. This program will focus on IP related issues that arise during negotiations and leave attendees with tips on identifying risks, reviewing viability of the patent portfolio, potential infringement issues, and managing outside counsel spend.

Collaborate with your peers across legal and regulatory disciplines to develop a compliant strategy for a healthcare technology product launch before your time runs out! Communicate to identify issues, assess and mitigate risks, complete tasks, and solve a variety of complications while remaining compliant. Boost your skills in communication, project management, issue spotting, and advising on matters such as intellectual property, access to data, and privacy laws that affect the company’s products and services as well as advising them on compliance with regulations governing technology products - all within an impending deadline.

This microlearning will cover the basics of what was Chevron deference, why it was struck down by the Supreme Court in the recent Loper Bright decision, and what it means for the health care industry. In particular, this microlearning will explain what has – and what has not – changed in this post-Chevron world.


Generously Sponsored By Foley & Lardner LLP

image

Subscribe to Health Law